Publicaciones en las que colabora con Jesus Oteo Iglesias (26)

2024

  1. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

2021

  1. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637

2020

  1. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 1

  2. Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes

    International Journal of Antimicrobial Agents, Vol. 55, Núm. 6

  3. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2017

  1. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287

  2. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2016

  1. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2131-2138

  2. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  3. Evaluation of the xpert carba-R (cepheid) assay using contrived bronchial specimens from patients with suspicion of ventilator-associated pneumonia for the detection of prevalent carbapenemases

    PLoS ONE, Vol. 11, Núm. 12

2015

  1. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain

    International Journal of Antimicrobial Agents, Vol. 46, Núm. 2, pp. 157-163

2014

  1. Inhibitor-resistant TEM- And OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 7, pp. 3874-3881

  2. Isolates of β-lactamase-negative ampicillin-resistant haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 1, pp. 111-116

2013

  1. Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli

    Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417

  2. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 5, pp. 1054-1059

  3. Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit

    Journal of Medical Microbiology, Vol. 62, Núm. PART4, pp. 571-575

2012

  1. Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 8, pp. 4540-4543

  2. Extended-spectrum-β-lactamase-producing Escherichia coli as a cause of pediatric infections: Report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 54-58

  3. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581

2010

  1. AmpC β-lactamases in Escherichia coli: Emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 3, pp. 270-276